@article{72064032961e497593cd394e12bbce63,
title = "How better drugs could change kala-azar control; lessons from a cost-effectiveness analysis",
keywords = "B780-tropical-medicine, Protozoal diseases, Leishmaniasis, Visceral, Kala azar, Drug therapy, Efficacy, Toxicity, Counterfeit drugs, Substandard drugs, Quality assurance, Compliance, Drug resistance, Drug development, Cost-effectiveness",
author = "M Boelaert and {Le Ray}, D and {Van der Stuyft}, P",
note = "ITG-H1A; ITG-P2A; ITG-HLA; MULTI; HEALTH; U-EPID; PARAS; U-PROTO; JIF; DOI; PDF; Reprints-R",
year = "2002",
doi = "10.1046/j.1365-3156.2002.00959.x",
language = "English",
volume = "7",
pages = "955--959",
journal = "Tropical Medicine and International Health",
issn = "1360-2276",
publisher = "John Wiley & Sons",
}